- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
First Helium
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
LGC Capital Gives Construction Update for Tricho-Med’s Facility
LGC Capital shared an update with shareholders on the construction of its Tricho-Med’s cannabis growing facility in Brownsburg, Quebec.
LGC Capital (TSXV:LG) shared an update with shareholders on the construction of its Tricho-Med’s cannabis growing facility in Brownsburg, Quebec.
As quoted in the press release:
Tricho-Med Expansion Plan
Tricho-Med has acquired 18 acres of additional land in close proximity to its site in Brownsburg, Quebec. The company now has the potential for a five-fold increase to its production capacity, compared to its original planned capacity at the time of the agreement with LGC in January 2018. This increase is further supported by the past purchase of approximately 20 acres of land adjacent to the facility currently under construction.
Tricho-Med plans to aggressively expand with a second facility beside its initial 34,000 square foot indoor growing operation, and it will be approximately 600,000 square feet. It will be a fully enclosed one-level building with potential for 475,000 square feet of flowering space. The combined facilities will have the potential to grow over 60,000 [kilograms] equivalent per year of dry cannabis and extracted products, based on actual industry observed yields of 30 grams per square foot per cycle when using the same production methods as Tricho-Med. All Tricho-Med products will be produced to strict Health Canada and EU-GMP standards for the domestic and international medical cannabis markets.
Click here to read the full press release.
Source: www.newswire.ca
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.